142 related articles for article (PubMed ID: 33208722)
1. Using Informatics to Build a Digital Health Footprint of Patients Living With Inherited Metabolic Disorders Identified by Newborn Screening.
Singh RH; Brown SJ; Hale PM; Narlow K; Gurung S; Salvatore ML; Tchamako JK
J Public Health Manag Pract; 2022 Mar-Apr 01; 28(2):E340-E344. PubMed ID: 33208722
[TBL] [Abstract][Full Text] [Related]
2. Long-term Outcomes of Individuals With Metabolic Diseases Identified Through Newborn Screening.
Mütze U; Garbade SF; Gramer G; Lindner M; Freisinger P; Grünert SC; Hennermann J; Ensenauer R; Thimm E; Zirnbauer J; Leichsenring M; Gleich F; Hörster F; Grohmann-Held K; Boy N; Fang-Hoffmann J; Burgard P; Walter M; Hoffmann GF; Kölker S
Pediatrics; 2020 Nov; 146(5):. PubMed ID: 33051224
[TBL] [Abstract][Full Text] [Related]
3. Newborn dried bloodspot screening: long-term follow-up activities and information system requirements.
Singh RH; Hinman AR
Genet Med; 2010 Dec; 12(12 Suppl):S261-6. PubMed ID: 21150373
[TBL] [Abstract][Full Text] [Related]
4. Developing a public health-tracking system for follow-up of newborn screening metabolic conditions: a four-state pilot project structure and initial findings.
Hinton CF; Mai CT; Nabukera SK; Botto LD; Feuchtbaum L; Romitti PA; Wang Y; Piper KN; Olney RS
Genet Med; 2014 Jun; 16(6):484-90. PubMed ID: 24310309
[TBL] [Abstract][Full Text] [Related]
5. Examination of the communication practices between state newborn screening programs and the medical home.
Kim S; Lloyd-Puryear MA; Tonniges TF
Pediatrics; 2003 Feb; 111(2):E120-6. PubMed ID: 12563084
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic contribution of metabolic workup for neonatal inherited metabolic disorders in the absence of expanded newborn screening.
Bower A; Imbard A; Benoist JF; Pichard S; Rigal O; Baud O; Schiff M
Sci Rep; 2019 Oct; 9(1):14098. PubMed ID: 31575911
[TBL] [Abstract][Full Text] [Related]
8. Newborn Screening for Inherited Metabolic Disorders: Early Identification and Long-Term Care for Patients in the Plain Community, Wisconsin, 2011-2017.
Held PK; Rice GM; Kuhl A; Drilias N; Baker M; Deline J; Spicer G; Sandrock C; Seroogy CM; Schwoerer JS
Public Health Rep; 2019; 134(2_suppl):58S-63S. PubMed ID: 31682555
[TBL] [Abstract][Full Text] [Related]
9. Acute care utilization for inherited metabolic diseases among children identified through newborn screening in New York state.
Wang Y; Sango-Jordan M; Caggana M
Genet Med; 2014 Sep; 16(9):665-70. PubMed ID: 24625447
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up data collection and use in state newborn screening programs.
Hoff T; Ayoob M; Therrell BL
Arch Pediatr Adolesc Med; 2007 Oct; 161(10):994-1000. PubMed ID: 17909144
[TBL] [Abstract][Full Text] [Related]
11. Differential diagnostics of inherited metabolic disorders in newborns.
Znamenska TK; Vorobiova OV; Holota ТV; Kryvosheieva VV; Pokhylko VI
Wiad Lek; 2020; 73(6):1211-1216. PubMed ID: 32723955
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation and optimization of newborn screening by structured long-term follow-up-using the example of inherited metabolic diseases].
Mütze U; Kölker S
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2023 Nov; 66(11):1249-1258. PubMed ID: 37815612
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of children with confirmed newborn screening disorders using record linkage.
Wang Y; Caggana M; Sango-Jordan M; Sun M; Druschel CM
Genet Med; 2011 Oct; 13(10):881-6. PubMed ID: 21637103
[TBL] [Abstract][Full Text] [Related]
14. A Population-Based Genomic Study of Inherited Metabolic Diseases Detected Through Newborn Screening.
Park KJ; Park S; Lee E; Park JH; Park JH; Park HD; Lee SY; Kim JW
Ann Lab Med; 2016 Nov; 36(6):561-72. PubMed ID: 27578510
[TBL] [Abstract][Full Text] [Related]
15. Long-term anthropometric development of individuals with inherited metabolic diseases identified by newborn screening.
Mütze U; Garbade SF; Gleich F; Lindner M; Freisinger P; Hennermann JB; Thimm E; Gramer G; Posset R; Krämer J; Grünert SC; Hoffmann GF; Kölker S
J Inherit Metab Dis; 2023 Jan; 46(1):15-27. PubMed ID: 36134599
[TBL] [Abstract][Full Text] [Related]
16. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
17. Mountain States Genetics Regional Collaborative Center's Metabolic Newborn Screening Long-term Follow-up Study: a collaborative multi-site approach to newborn screening outcomes research.
Wright EL; Van Hove JL; Thomas J;
Genet Med; 2010 Dec; 12(12 Suppl):S228-41. PubMed ID: 21150369
[TBL] [Abstract][Full Text] [Related]
18. Good laboratory practices for biochemical genetic testing and newborn screening for inherited metabolic disorders.
Centers for Disease Control and Prevention (CDC)
MMWR Recomm Rep; 2012 Apr; 61(RR-2):1-44. PubMed ID: 22475884
[TBL] [Abstract][Full Text] [Related]
19. Inherited metabolic disorders in the neonatal intensive care unit: Red flags to look out for.
Eminoğlu FT; Koç Yekedüz M; Doğulu N; Öncül Ü; Köse E; Okulu E; Erdeve Ö; Atasay B; Arsan S
Pediatr Int; 2022 Jan; 64(1):e14953. PubMed ID: 34390086
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up in newborn screening: A systems approach for improving health outcomes.
Lloyd-Puryear MA; Brower A
Genet Med; 2010 Dec; 12(12 Suppl):S256-60. PubMed ID: 21150372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
